When Should You Have a PET-CT — After Chemotherapy?

There is no single number that applies to every patient. At least three weeks from your last cycle is a common minimum for most regimens, but your oncologist may recommend longer depending on the drugs used, how many cycles you had, and how well you have recovered. Bone marrow activity after G-CSF support may require additional time. Ask your oncologist what gap they are planning for your situation specifically, rather than relying on a general figure.

Not necessarily. Earlier scans can be appropriate when the clinical question is urgent — staging before surgery, for example, rather than response assessment after treatment. The purpose of the scan changes the timing logic. Ask your team what question the scan is answering and whether the timing accounts for post-treatment inflammation. If you are still unsure after that conversation, it is entirely reasonable to ask your oncologist to walk you through the reasoning.

Yes, but correction takes time and effort. A follow-up scan weeks later, or a biopsy of the area in question, are the usual ways to clarify a confusing result. Both add delay, additional procedures, and weeks of uncertainty. This is why avoiding an early scan is the better approach wherever clinically possible. If your result is unexpected, ask your team whether the finding is consistent with post-treatment inflammation or whether further investigation is needed.

Yes. Different regimens cause different patterns and durations of post-treatment inflammation. Some drugs cause more prolonged bone marrow activity than others. Mentioning any complications, changes to your planned regimen, or growth factor support you received helps your team choose the right timing. Your oncologist decides the wait with your specific treatment in mind, not a generic schedule.

This is a very common concern, and it deserves a direct answer. The waiting period is not passive — it is the time during which treatment is completing its effect and inflammation is settling. Scanning into that inflammation does not give a clearer picture; it gives a noisier one that can mislead the next decision. If you develop new symptoms during the gap — a new lump, significant pain, or something that feels different — tell your team straight away, because that is a clinical reason to reassess.

CION coordinates PET-CT with partner imaging centres rather than operating the scanner in the clinic. Once your oncologist decides you are ready, the referral and booking are arranged through your treating team. If you have a time-sensitive reason — a planned surgery or a clinical trial deadline — mention it early so the timing can be planned around it.